Why the study?
Does baseline platelet count within the normal range predict recurrent stroke, mortality, and poor functional outcomes in patients with ischemic stroke or TIA?
Does baseline platelet count within the normal range predict recurrent stroke, mortality, and poor functional outcomes in patients with ischemic stroke or TIA?
In patients with ischemic stroke or TIA, a high-normal baseline platelet count is associated with an increased risk of recurrent stroke, mortality, and poor functional outcomes at one year.
No takes yet. Share an insight, caveat, or question.
May refine post-stroke risk stratification by normal-range PC; leaves open whether targeting PC improves outcomes.
Yang et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: